SUPN - SUPERNUS PHARMACEUTICALS, INC.
53.87
-0.400 -0.743%
Share volume: 643,456
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$54.27
-0.40
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-04-2024 | 02-25-2025 | 05-06-2025 | 08-05-2025 | 11-06-2025 | 03-02-2026 | |
| Total revenue | 143.644 M | 168.325 M | 175.689 M | 174.159 M | 149.824 M | 165.453 M | 192.103 M | 211.572 M | |
| Cost of revenue | 16.309 M | 17.916 M | 17.583 M | 26.098 M | 15.763 M | 16.827 M | 18.965 M | 23.007 M | |
| Gross profit | 127.335 M | 150.409 M | 158.106 M | 148.061 M | 134.061 M | 148.626 M | 173.138 M | 188.565 M | |
| 18.12% | 5.12% | -6.35% | -9.46% | 10.86% | 16.49% | 8.91% | |||
| Operating expenses | 111.446 M | 112.087 M | 98.789 M | 108.056 M | 116.871 M | 115.666 M | 209.044 M | 150.217 M | |
| Selling general and admin | 86.516 M | 85.904 M | 69.753 M | 79.409 M | 89.944 M | 93.551 M | 179.678 M | 122.390 M | |
| Research and development | 24.930 M | 26.183 M | 29.036 M | 28.647 M | 26.927 M | 22.115 M | 29.366 M | 27.827 M | |
| Total expenses | 147.892 M | 127.840 M | 117.261 M | 126.656 M | 144.317 M | 136.485 M | 233.369 M | 192.502 M | |
| -13.56% | -8.28% | 8.01% | 13.94% | -5.43% | 70.99% | -17.51% | |||
| Operating income | -4.248 M | 22.569 M | 40.845 M | 21.405 M | -10.256 M | 12.141 M | -60.231 M | -3.937 M | |
| Ebit | -4.248 M | 26.302 M | 44.943 M | 26.382 M | -5.831 M | 16.669 M | -57.954 M | -1.914 M | |
| Pretax income | 243.000 K | 26.302 M | 44.943 M | 26.382 M | -5.831 M | 16.669 M | -57.954 M | -1.914 M | |
| 10,723.87% | 70.87% | -41.30% | -122.10% | -385.87% | -447.68% | -96.70% | |||
| Income tax | 119.000 K | 6.386 M | 6.446 M | 11.054 M | 5.996 M | -5.830 M | -12.837 M | 2.191 M | |
| Net income basic | 124.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | |||||||||
| Net income | 124.000 K | 19.916 M | 38.497 M | 15.328 M | -11.827 M | 22.499 M | -45.117 M | -4.105 M | |
| 15,961.29% | 93.30% | -60.18% | -177.16% | 290.23% | -300.53% | 90.90% |